Bayer Aktiengesellschaft (BAYRY) Stock Forecast & Price Target

$8.41

-0.06 (-0.71%)

(As of 10/1/2024 ET)

Bayer Aktiengesellschaft - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce

Based on 9 Analyst Ratings

Sell
1

Hold
8

Buy
0

Based on 9 Wall Street analysts who have issued ratings for Bayer Aktiengesellschaft in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 9 analysts, 1 has given a sell rating, and 8 have given a hold rating for BAYRY.

Consensus Price Target

N/A

Get the Latest News and Ratings for BAYRY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bayer Aktiengesellschaft and its competitors.

BAYRY Analyst Ratings Over Time

Type	Current Forecast 10/3/23 to 10/2/24	1 Month Ago 9/3/23 to 9/2/24	3 Months Ago 7/5/23 to 7/4/24	1 Year Ago 10/3/22 to 10/3/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Reduce	Reduce	Reduce	Hold

[Urgent!] Web3 Could Send One Crypto Soaring (Ad)

Venture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years.

Click here to review my research and unique strategy to score potential profits from this under-the-

BAYRY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BAYRY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bayer Aktiengesellschaft Stock vs. The Competition

Type	Bayer Aktiengesellschaft	Medical Companies	S&P 500
Consensus Rating Score	1.89	2.78	2.50
Consensus Rating	Reduce	Moderate Buy	Hold
Predicted Upside	N/A	813.43% Upside	6.86% Upside
News Sentiment Rating	Neutral News See Recent BAYRY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target
9/6/2024	Bank of America 4 of 5 stars	Upgrade	Underperform ➝ Neutral
5/30/2024	The Goldman Sachs Group 2 of 5 stars	Initiated Coverage	Neutral
3/7/2024	Sanford C. Bernstein 3 of 5 stars	Reiterated Rating	Outperform ➝ Market Perform
2/29/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
1/30/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
12/18/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Reduce
12/4/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
11/21/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
11/14/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
9/25/2023	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
8/16/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
1/6/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight
1/3/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
11/9/2022	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	€69.00 ➝ €54.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:14 AM ET.

BAYRY Forecast - Frequently Asked Questions

: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last year. There is currently 1 sell rating and 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" BAYRY shares.
: According to analysts, Bayer Aktiengesellschaft's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Over the previous 90 days, Bayer Aktiengesellschaft's stock had 1 upgrade by analysts.
: Bayer Aktiengesellschaft has been rated by research analysts at Bank of America in the past 90 days.
: Analysts like Bayer Aktiengesellschaft less than other "medical" companies. The consensus rating for Bayer Aktiengesellschaft is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BAYRY compares to other companies.